Newsbenzinga
AstraZeneca, Daiichi Sankyo Expand Cancer Push Through Summit Partnership
· Published
Article summary
AstraZeneca & Daiichi Sankyo team up with Summit Therapeutics to test Datroway + ivonescimab combo in triple-negative breast cancer.
An excerpt from the original article.
Comments —
Loading comments…